| Patient | Sonny Liston |
|---|---|
| Date of birth | 1932-05-08 |
| Identifiers | MRN HR-BX007-SYN-TD; SSN (made up) 000-07-8853 |
| Document date | 1969-10-20 |
| Author | Malcolm Achebe-Whitford, MD |
| Custodian | St. Posthumous Health Center |
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
Four-month review of blood pressure and drinking. [S]
Sonny Liston returns for his four-month review. The commission physician cleared him to box after reviewing his readings, and he is back to full sparring. His home readings average 120/76 mmHg. He takes amlodipine 10 mg and valsartan 160 mg and naltrexone 50 mg each morning. He drinks about eight drinks a week, never more than three in a day, and none in the two weeks before a bout. He is sleeping well and says he feels sharper in training. He has thought about the adult reading class he was told about and wants to wait until after his next fight. No thoughts of suicide. [S]
| Element | Detail |
|---|---|
| Home readings | Average 120/76 mmHg |
| AUDIT | 7, from 16 at intake |
| GGT | 41 U/L, normal |
| PHQ-9 | 2; item 9 scored 0 |
| Vaccine today | Influenza |
| System | Result | Finding |
|---|---|---|
| Cardiovascular | Negative | No chest pain, palpitations or swelling at rest |
| Neurological | Negative | No dizziness or headaches |
| Gastrointestinal | Negative | No nausea |
| Psychiatric | Negative | Mood good; no thoughts of suicide |
4 systems reviewed. [S]
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|---|---|---|---|---|
| Amlodipine 5 mg and valsartan 160 mg combined oral tablet, one tablet each morning | One tablet each morning | Oral route | 1969-06-23 to 1969-07-21 | completed | S |
| Amlodipine 10 mg and valsartan 160 mg combined oral tablet, one tablet each morning | One tablet each morning | Oral route | 1969-07-21 | active | S |
| Naltrexone 50 mg oral tablet, one tablet each morning | One tablet each morning | Oral route | 1969-07-21 | active | S |
| Pseudoephedrine 30 mg oral tablet, bought over the counter as a cold tablet, two tablets up to four times a day | Two tablets up to four times a day | Oral route | 1969-09-05 to 1969-09-08 | stopped | S |
| Acetaminophen 500 mg oral tablet, one or two tablets every six hours as needed for aches, no more than four tablets (2 g) a day because he drinks | One or two tablets every six hours as needed; no more than four tablets a day | Oral route | 1969-09-08 to 1969-09-15 | completed | S |
| Saline nasal spray 0.65%, two sprays in each nostril as needed | Two sprays in each nostril as needed | Nasal route | 1969-09-08 to 1969-09-15 | completed | S |
| Allergy | Reaction | Status | Evidence |
|---|---|---|---|
| No known allergy | active | S |
| Date | Measure | Value | Unit | Provenance |
|---|---|---|---|---|
| 1969-10-20 | Body height | 185 | cm | S |
| 1969-10-20 | Body weight | 97 | kg | S |
| 1969-10-20 | Body mass index (BMI) [Ratio] | 28.3 | kg/m2 | S |
| 1969-10-20 | Systolic blood pressure | 122 | mm[Hg] | S |
| 1969-10-20 | Diastolic blood pressure | 76 | mm[Hg] | S |
| 1969-10-20 | Heart rate | 56 | /min | S |
| 1969-10-20 | Respiratory rate | 14 | /min | S |
| 1969-10-20 | Body temperature | 36.5 | Cel | S |
| 1969-10-20 | Oxygen saturation in Arterial blood by Pulse oximetry | 99 | % | S |
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
|---|---|---|---|---|---|---|
| 1969-10-20 | Total score [AUDIT] | 7 | {score} | S | ||
| 1969-10-20 | Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma | 41 | U/L | 8-61 U/L | Normal | S |
| 1969-10-20 | Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] | 2 | {score} | S |
Vital signs recorded on 1969-10-20; see the Vital Signs section. [S]
| System | Finding |
|---|---|
| General | Well; blood pressure 122/76 mmHg (average of two); pulse 56; weight 97.0 kg |
| Cardiovascular | Regular rhythm; no edema |
| Problem | Clinical status | Verification | Code | Provenance |
|---|---|---|---|---|
| High blood pressure readings at a first visit (154/98 mmHg, average of two readings with a large cuff), without a diagnosis of hypertension; out-of-office confirmation needed | resolved | confirmed | R03.0 | S — Synthetic presenting finding; resolved into the diagnosis at the consultation visit when ambulatory monitoring confirmed hypertension. |
| Hypertension, stage 2, confirmed by 24-hour ambulatory monitoring (daytime average 146/94 mmHg, nighttime 132/84 mmHg), with mild concentric left ventricular hypertrophy on echocardiography and normal kidney function and urine albumin | active | confirmed | I10 | S — Synthetic modern diagnosis; no hypertension is documented in his life. |
| Alcohol use disorder, moderate (four DSM-5-TR criteria: drinking more than intended, unsuccessful efforts to cut down, craving, and continued drinking despite its effect on his training, blood pressure and liver tests); AUDIT 16 | active | confirmed | F10.20 | S — Synthetic modern diagnosis by interview, anchored to the description of heavy drinking; not a historical diagnosis. |
| Personal history of physical abuse in childhood (beaten regularly by his father), with heavy field work from the age of eight | active | confirmed | Z62.810 | S — Synthetic coding of the documented childhood history; physical abuse only. |
| Does not read or write (no schooling as a child); prefers spoken explanations, pictures and demonstrations | active | confirmed | Z55.0 | S — Synthetic coding of the documented literacy, recorded so that care is adapted. |
| Acute viral upper respiratory infection (common cold) for four days, with blood pressure raised to 158/98 mmHg by an over-the-counter pseudoephedrine cold tablet he could not read the label of; resolved | resolved | confirmed | J06.9 | S — Synthetic acute illness; not a historical claim. |
Protocol monitoring: items the monitoring protocol calls for at this visit. [S]
| Domain | Measure | Interval | Status | Detail |
|---|---|---|---|---|
| Examination | Office blood pressure (seated, large cuff, average of two readings), weight and BMI, heart sounds | Every visit | Completed today | 122/76 mmHg; weight 97.0 kg |
| Examination | Out-of-office blood pressure (ambulatory or home monitoring) | At diagnosis and after each treatment change | Completed today | Home average 120/76 mmHg |
| Laboratory | Potassium, creatinine and eGFR | Baseline; two to four weeks after starting an ARB; then every six months on an ARB | Due | Next in about two months, six months after starting valsartan |
| Laboratory | Lipids, glucose or A1c, urine albumin-to-creatinine ratio, TSH | At diagnosis, then yearly (TSH at diagnosis) | Up to date | Done at intake; next at the preventive visit next year |
| Imaging | Echocardiogram | At diagnosis for stage 2 hypertension or suspected LVH; repeat as indicated | Up to date | Repeat in about eight months |
| Medication safety | Antihypertensive tolerance (ankle edema, dizziness) and adherence by teach-back | Each follow-up and each dose change | Completed today | No edema today; no dizziness; teach-back correct |
| Referral | Fitness to compete (AHA/ACC athlete statement) | At diagnosis and before returning to competition | Completed today | Cleared by the commission physician; blood pressure checked before each bout |
| Survey | Drinking (AUDIT-C, drinks per week, drinking days) | Every follow-up during treatment; full AUDIT at about four months | Completed today | Full AUDIT 7, from 16; about 8 drinks a week |
| Laboratory | Liver tests (AST, ALT, GGT) | Baseline; about two months after starting naltrexone or cutting down; then as indicated | Completed today | GGT 41 U/L, now normal |
| Medication safety | Naltrexone: nausea, liver tests, and opioid-blockade wallet card | Each follow-up after starting | Completed today | Well tolerated; wallet card carried |
| Survey | PHQ-9 | Yearly with hypertension; sooner with symptoms | Completed today | PHQ-9 2, item 9 scored 0 |
| Survey | Suicide-risk review (structured questions) and safety plan | Every visit | Completed today | No thoughts of suicide; safety plan kept |
| Self-management | Health literacy: teach-back, picture card, read-aloud consent, voice reminders | Every visit | Completed today | Teach-back correct; the adult reading class offered again, and he will decide after his next fight |
Goal progress:
Immunizations given today: Influenza vaccine, 1969-1970 season [S]
Guideline basis: 2025 AHA/ACC/AANP/AAPA/ABC/ACCP/ACPM/AGS/AMA/ASPC/NMA/PCNA/SGIM Guideline for the Prevention, Detection, Evaluation and Management of High Blood Pressure in Adults (2025); CMID: Clinical Monitoring Intelligence Database, hypertension and depression monographs (2026); Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 6: Hypertension (Black HR, et al.) (2015); The Healthcare Professional's Core Resource on Alcohol (2026); The American Psychiatric Association Practice Guideline for the Pharmacological Treatment of Patients With Alcohol Use Disorder (2018); VA/DoD Clinical Practice Guideline for Assessment and Management of Patients at Risk for Suicide (2024); AHRQ Health Literacy Universal Precautions Toolkit, 3rd Edition (2024); Adult Immunization Schedule by Age (2026)
Follow-up: Potassium and creatinine in about two months. Review in three months, sooner after any bout with a head injury. Preventive visit in ten months. Call 988 or the clinic at any time if thoughts of suicide arise. [S]